QLY Biotech Group Corp.
QLY Biotech Group Corp. engages in the tourism business in the Dominican Republic. It organizes individual and group sailing tours. The company was formerly known as Azar International Corp. and changed its name to QLY Biotech Group Corp. in August 2022. QLY Biotech Group Corp. was incorporated in 2018 and is based in Las Vegas, Nevada.
Market Cap & Net Worth: QLY Biotech Group Corp. (LQLY)
QLY Biotech Group Corp. (PINK:LQLY) has a market capitalization of $3.90 Million ($3.90 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #36299 globally and #11806 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying QLY Biotech Group Corp.'s stock price $1.00 by its total outstanding shares 3895000 (3.90 Million).
QLY Biotech Group Corp. Market Cap History: 2022 to 2025
QLY Biotech Group Corp.'s market capitalization history from 2022 to 2025. Data shows growth from $4.09 Million to $3.90 Million (0.00% CAGR).
QLY Biotech Group Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how QLY Biotech Group Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LQLY by Market Capitalization
Companies near QLY Biotech Group Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to QLY Biotech Group Corp. by market ranking:
- Booking Holdings Inc (NASDAQ:BKNG): Ranked #129 globally with a market cap of $140.30 Billion USD.
- Royal Caribbean Cruises Ltd (NYSE:RCL): Ranked #298 globally with a market cap of $71.80 Billion USD.
- Airbnb Inc (NASDAQ:ABNB): Ranked #405 globally with a market cap of $53.81 Billion USD.
- AIRBNB INC. DL-01 (F:6Z1): Ranked #454 globally with a market cap of $47.87 Billion USD ( €46.64 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Booking Holdings Inc | NASDAQ:BKNG | $140.30 Billion | $4442.33 |
| #298 | Royal Caribbean Cruises Ltd | NYSE:RCL | $71.80 Billion | $277.90 |
| #405 | Airbnb Inc | NASDAQ:ABNB | $53.81 Billion | $131.95 |
| #454 | AIRBNB INC. DL-01 | F:6Z1 | $47.87 Billion | €114.30 |
QLY Biotech Group Corp. Historical Marketcap From 2022 to 2025
Between 2022 and today, QLY Biotech Group Corp.'s market cap moved from $4.09 Million to $ 3.90 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.90 Million | 0.00% |
| 2024 | $3.90 Million | 0.00% |
| 2023 | $3.90 Million | -4.76% |
| 2022 | $4.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of QLY Biotech Group Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.90 Million USD |
| MoneyControl | $3.90 Million USD |
| MarketWatch | $3.90 Million USD |
| marketcap.company | $3.90 Million USD |
| Reuters | $3.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.